fda glp-1 safety alert october 2025 US removes suicidal thoughts warning from weight-loss drugs FIRST GLP-1 PILL: The FDA

As we all understand how antioxidants play a significant role in detoxification, boosting immunity and optimizing overall health

Vining et al

Antimllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin

Most recently, in March 2025, the district court denied the plaintiffs motion for a preliminary injunction, finding FDAs decision to remove tirzepatide from the drug shortage list was proper

Saxenda (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with obesity or overweight (excess weight) who also have weight-related medical problems, and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off

Experimental studies have explored its effects on: Tendons Ligaments Muscles Connective tissue Blood vessel development Most of these findings come from animal studies, so more human research is needed